ALEC
ALEC
NASDAQ · Biotechnology

Alector Inc

$1.92
-0.03 (-1.54%)
As of Sep 28, 10:15 PM ET ·
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Buy 8 57%
Hold 4 29%
Sell 2 14%
Price Target
Analyst Price Target +1,009.4% upside
Low Target $14.71
Average Target $21.30
High Target $34.17
Current Price $1.92
Current
$1.92
Target
$21.30
$14.71 $21.30 avg $34.17
Scenario Analysis
Bear Case
$14.71
666.1%
Low target
Base Case
$21.30
+1,009.4%
Avg target
Bull Case
$34.17
+1,679.7%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$3.40
-43.5% from high
52-Week Low
$1.09
+76.1% from low
Target vs 52W High
$21.30
+526.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%